ADMA — ADMA BIOLOGICS INC

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 30,519 -14,297 -31.9% 0.00% $447K $14.66
2024 Q4 INITIATED 44,816 — — 0.01% $769K $17.15
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Freestone Grove Partners LP Holdings